#complete-response-rate
Latest news and interesting information about complete-response-rate.
Immix Biopharma reports 95% complete response rate in trial
Immix Biopharma's NEXICART-2 trial achieves 95% complete response rate in AL Amyloidosis patients. Promising results for CAR-T therapy NXC-201.
...
